Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Maximal Use Trial of Ruxolitinib Cream in Adult Participants With Prurigo Nodularis

NCT06213831 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT06213831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06213831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Maximal Use Trial of Ruxolitinib Cream in Adult Participants With Prurigo Nodularis
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Completed
Start date
February 27, 2024
Completion date
July 17, 2025
Enrollment
23 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

prurigo nodularis